The risks and rewards of gene-editing
FT Tech Tonic - Un pódcast de Financial Times
Categorías:
Robin Lovell-Badge, developmental biologist and geneticist, talks to FT science columnist Anjana Ahuja about the gene-edited babies controversy in China and about the potential for new gene-editing techniques to transform the treatment of diseases like cancer and muscular dystrophy. For information regarding your data privacy, visit acast.com/privacy
